Investigation of the estrogen receptor-α gene with type 2 diabetes and/or nephropathy in African-American and European-American populations

Diabetes

Volumn 56, Issue 3, 2007, Pages 675-684

  Gallagher, Carla J ^a   Keene, Keith L ^a   Mychaleckyj, Josyf C ^a   Langefeld, Carl D ^a   Hirschhorn, Joel N ^b,c   Henderson, Brian E ^d   Gordon, Candace J ^a   Freedman, Barry I ^a   Rich, Stephen S ^a   Bowden, Donald W ^a   Sale, Michèle M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ESTROGEN RECEPTOR ALPHA; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33847390795     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0303     Document Type: Article

References (53)

1. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259, 2000
2. Sale MM, Freedman BI, Langefeld CD, Williams AH, Hicks PJ, Colicigno CJ, Beck SR, Brown WM, Rich SS, Bowden DW: A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes 53:830-837, 2004
3. Livingstone C, Collison M: Sex steroids and insulin resistance. Clin Sci (Lond) 102:151-166, 2002
4. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS: Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97:12729-12734, 2000
5. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061, 1994
6. Speer G, Cseh K, Winkler G, Vargha P, Braun E, Takacs I, Lakatos P: Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144:385-389, 2001
7. Hollingsworth DR: Alterations of maternal metabolism in normal and diabetic pregnancies: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Am J Obstet Gynecol 146:417-429, 1983
8. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV: Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 72:277-282, 1991
9. Bloch CA, Clemons P, Sperling MA: Puberty decreases insulin sensitivity. J Pediatr 110:481-487, 1987
10. Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V: Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 74:64-70, 1992
11. Cohen JC, Hickman R: Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 64:960-963, 1987
12. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER: Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346:967-974, 2002
13. Herrington DM, Howard TD: ER-alpha variants and the cardiovascular effects of hormone replacement therapy. Pharmacogenomics 4:269-277, 2003
14. Kikuchi T, Hashimoto N, Kawasaki T, Uchiyama M: Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 89:42-45, 2000
15. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW: Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 15:1794-1800, 2000
16. Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW: Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics 69:225-234, 2000
17. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Linkage analysis between loci in the renin-angiotensin axis and end-stage renal disease in African Americans. J Am Soc Nephrol 7:2559-2564, 1996
18. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI: Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 31:906-911, 1998
19. Shriver MD, Parra EJ, Dios S, Bonilla C, Norton H, Jovel C, Pfaff C, Jones C, Massac A, Cameron N, Baron A, Jackson T, Argyropoulos G, Jin L, Hoggart CJ, McKeigue PM, Kittles RA: Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 112:387-399, 2003
20. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A: High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A 98:581-584, 2001
21. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 296:2225-2229, 2002
22. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 37:1217-1223, 2005
23. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265, 2005
24. Green LE, Lange EM, Langefeld CD: Power comparisions of phase-known versus phase-unknown haplotype analyses for case-control designs (Abstract). Am J Hum Genet 69:1948a, 2001
25. McKeigue PM, Carpenter JR, Parra EJ, Shriver MD: Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Intern Med 64:171-186, 2000
26. Deng HW, Li J, Li JL, Dowd R, Davies KM, Johnson M, Gong G, Deng H, Recker RR: Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 85:2748-2751, 2000
27. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H: Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord 27:1020-1027, 2003
28. Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM, Levy D, Mendelsohn ME, Housman DE, Shearman AM: Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab 90:6257-6262, 2005
29. Shearman AM, Demissie S, Cupples LA, Peter I, Schmid CH, Ordovas JM, Mendelsohn ME, Housman DE: Tobacco smoking, estrogen receptor alpha gene variation and small low density lipoprotein level. Hum Mol Genet 14:2405-2413, 2005
30. Demissie S, Cupples LA, Shearman AM, Gruenthal KM, Peter I, Schmid CH, Karas RH, Housman DE, Mendelsohn ME, Ordovas JM: Estrogen receptor-alpha variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis 185:210-218, 2006
31. Nordstrom P, Glader CA, Dahlen G, Birgander LS, Lorentzon R, Waldenstrom A, Lorentzon M: Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 254:140-146, 2003
32. Poola I, Koduri S, Chatra S, Clarke R: Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J Steroid Biochem Mol Biol 72:249-258, 2000
33. Poola I, Speirs V: Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 78:459-469, 2001
34. Bollig A, Miksicek RJ: An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol Endocrinol 14:634-649, 2000
35. Thompson DB, de Gregorio M, Sommercorn J: Insulin regulation of multiple ribonucleic acid species in human skeletal muscle in insulinsensitive and insulin-resistant subjects. J Clin Endocrinol Metab 81:519-523, 1996
36. Hyder SM, Nawaz Z, Chiappetta C, Yokoyama K, Stancel GM: The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem 270:8506-8513, 1995
37. Pethe V, Shekhar PV: Estrogen inducibility of c-Ha-ras transcription in breast cancer cells: identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J Biol Chem 274:30969-30978, 1999
38. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829-839, 1998
39. Tcherepanova I, Puigserver P, Norris JD, Spiegelman BM, McDonnell DP: Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1. J Biol Chem 275:16302-16308, 2000
40. Andersen GHT, Gharani N, Frayling TM, Owen KR, Sampson M, Ellard S, Walker M, Hitman GA, Hattersley AT, McCarthy MI Pedersen O: A common Gly482Ser polymorphism of PGC-1 is associated with type 2 diabetes in two European populations (Abstract). Diabetes 51:A49, 2002
41. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O: Mutation analysis of peroxisome proliferatoractivated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44:2220-2226, 2001
42. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, Kimura S, Kadowaki T: A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45:740-743, 2002
43. Lacquemant C, Chikri M, Boutin P, Samson C, Froguel P: No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and type II diabetes in French Caucasians. Diabetologia 45:602-603, author reply 604, 2002
44. Oberkofler H, Linnemayr V, Weitgasser R, Klein K, Xie M, Iglseder B, Krempler F, Paulweber B, Patsch W: Complex haplotypes of the PGC-1α gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53:1385-1393, 2004
45. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003
46. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466-8471, 2003
47. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD: Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63:1839-1851, 1998
48. Cooke PS, Heine PA, Taylor JA, Lubahn DB: The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 178:147-154, 2001
49. Wells CC, Riazi S, Mankhey RW, Bhatti F, Ecelbarger C, Maric C: Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors. Gend Med 2:227-237, 2005
50. Sun J, Langer WJ, Devish K, Lane PH: Compensatory kidney growth in estrogen receptor-alpha null mice. Am J Physiol Renal Physiol 290:F319-F323, 2006
51. Salyakina D, Seaman SR, Browning BL, Dudbridge F, Muller-Myhsok B: Evaluation of Nyholt's procedure for multiple testing correction. Hum Hered 60:19-25, discussion 61-12, 2005
52. Li C, Scott LJ, Boehnke M: Assessing whether an allele can account in part for a linkage signal: the Genotype-IBD Sharing Test (GIST). Am J Hum Genet 74:418-431, 2004
53. Galan JJ, Buch B, Cruz N, Segura A, Moron FJ, Bassas L, Martinez-Pineiro L, Real LM, Ruiz A: Multilocus analyses of estrogen-related genes reveal involvement of the ESR1 gene in male infertility and the polygenic nature of the pathology. Fertil Steril 84:910-918, 2005